Artery Stenosis Drug Market 2019 Analysis by Current Industry Status & Growth Opportunities, Top Key Players, Target Audience and Forecast to 2026

Artery Stenosis Drug Market 2019, A recent report published by Data Bridge Market Research provides a unique guidance in thoughtful details regarding the development factors, used a top-down and bottom-up approach to keep it error-free and accurate. The researchers have used primary and secondary methodologies to collect data and its analysis.

Market Segment by Companies, this report covers Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Baxter, Medtronic, Johnson & Johnson Services, Inc, Cook Group among others.

Click More Info| Get Sample Report @


Artery stenosis is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

According to W.H.O, cardiovascular diseases accounts for the most deaths globally than any other cause. In 2016, approximately 17.9 million people died from cardiovascular diseases, representing 31% of all global deaths, out of these deaths, 85% are due to stroke and heart attack.

Segmentation of the market

  • By Indication Type (Carotid Artery Stenosis, Renal Artery Stenosis, Peripheral Artery Stenosis, Coronary Artery Stenosis and Others),
  • Treatment (Medication and Surgery),
  • Drugs (Atorvastatin, Fluvastatin, Heparin, Minoxidil, Aspirin and Others),
  • Route of Administration (Oral, Intravenous),
  • Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy),
  • End-Users (Hospitals, Homecare, Specialty Clinics, Others)

Geographical landscape covered in the report

This ARTERY STENOSIS DRUG report covers a geographical landscape including the region like North America, South America, Asia and Pacific region, Middle East and Africa and Europe.  Other vital key regions are also taken into account while developing this report.

For Early Buyers | Get Up to 30% Discount on This Report:

Key Developments in the Market

In February 2019, M.A. MedAlliance SA received Breakthrough Device designation from the U.S FDA for selution, sirolimus, sustained limus release (SLR) drug-eluting balloon (DEB) catheter, to treat coronary disease. This designation will provide company with the priority review and assistance from the FDA regarding device development and its approval.

In October 2018, Johnson & Johnson Services, Inc received the U.S FDA approval for Xarelto (rivaroxaban), factor Xa (FXa) inhibitor for the treatment of chronic coronary or peripheral artery disease. This drug is specifically approved for reducing the risk of major cardiovascular disorders such as stroke and myocardial infarction in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).

Questions related to the report:

  • What does this ARTERY STENOSIS DRUG market research report offers?

This ARTERY STENOSIS DRUG report helps you to find about the key industry trends, threats and opportunities. It informs your decision for marketing strategy and planning.  The most important its ARTERY STENOSIS DRUG report helps you to quickly build competitive intelligence in this rapidly changing market.

  • Which techniques are utilized to overcome the threats?

Before creating this ARTERY STENOSIS DRUG report different type of tools and techniques such as SWOT analysis, Porter’s five analysis, Pestle Analysis, Industry chain analysis are utilized which helps the readers to overcome the threats of the market.

Market Drivers and Restraints

  • Increasing adoption of an unhealthy lifestyle is boosting the market growth
  • Rising prevalence of diabetes and obesity will also accelerate the market for artery stenosis drug
  • Improvement of healthcare infrastructure in developing economies is enhancing the market growth
  • High cost of diagnostics and surgeries is hindering the market in the forecast period
  • Issue of restenosis even after the treatment may restrain the market growth

Major Points Covered in Table of Contents:

  • Global Artery Stenosis Drug Platforms Market Overview
  • Economic Impact on Industry
  • Market Competition by Manufacturers
  • Production, Revenue (Value) by Region
  • Supply (Production), Consumption, Export, Import by Regions
  • Production, Revenue (Value), Price Trend by Type
  • Global Artery Stenosis Drug Platforms Market Analysis by Application
  • Manufacturing Cost Analysis
  • Industrial Chain, Sourcing Strategy and Downstream Buyers
  • Marketing Strategy Analysis, Distributors/Traders
  • Market Effect Factors Analysis
  • Global Artery Stenosis Drug Platforms Market Forecast

Read Complete Details with TOC @                


This ARTERY STENOSIS DRUG research report gives the outcome that matters most to the client. The research carried out in this report suggests what is going to be beneficial and how the report will help the business to grow.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *